News

Keeping you current on new and follow-on investments, portfolio product and service milestones, publications and events, management and board transitions, and other developments in Tullis funds.

January

26

electroCore, Inc. Announces Exclusive Distribution Agreement with RSK Medical Inc. in Canada

RSK Medical will serve as exclusive distributor of the gammaCore Sapphire™ in Canada, supplying therapy...

21

Exagen Inc. Partners with Boston’s Tufts Medical Center to Offer AVISE® Testing as an In-Network Benefit for Patients Suffering from Debilitating Autoimmune Diseases

SAN DIEGO, Jan. 21, 2021 (GLOBE NEWSWIRE) — Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the...

21

electroCore, Inc. Announces Scottish Health Technology Group Recommendation For Use of gammaCore™ in NHS Scotland Cluster Headache Patients

Publication based on guidance produced in 2019 by the U.K. National Institute for Health and...

19

electroCore, Inc. Announces the Establishment of a Unique Level II HCPCS Code for “Non-Invasive Vagus Nerve Stimulator”

Decision covering gammaCore Sapphire™ D will go into effect April 1, 2021 ROCKAWAY, N.J., Jan. 19,...

12

ATEC Announces Preliminary 2020 Revenue Results

Full-year 2020 U.S. revenue growth exceeded 30%; fourth quarter 2020 U.S. revenue grew over 38%...

11

electroCore Provides Business Update and Select Financial Guidance

Full year 2020 revenue expected at the upper end of previously announced guidance range...

10

Exagen Inc. Reports Preliminary Fourth Quarter 2020 Testing Results

Record Testing Revenue, Adopters and AVISE CTD® Volumes SAN DIEGO, Jan. 10, 2021 (GLOBE NEWSWIRE) — Exagen Inc. (Nasdaq:...